- Home
- MHO vs APGE Comparison
MHO vs APGE Comparison
Compare MHO & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MHO
- APGE
- Stock Information
- Founded
- MHO 1976
- APGE 2022
- Country
- MHO United States
- APGE United States
- Employees
- MHO N/A
- APGE N/A
- Industry
- MHO Homebuilding
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MHO Consumer Discretionary
- APGE Health Care
- Exchange
- MHO Nasdaq
- APGE Nasdaq
- Market Cap
- MHO 3.5B
- APGE 3.0B
- IPO Year
- MHO 1986
- APGE 2023
- Fundamental
- Price
- MHO $156.14
- APGE $42.86
- Analyst Decision
- MHO Buy
- APGE Strong Buy
- Analyst Count
- MHO 3
- APGE 5
- Target Price
- MHO $197.50
- APGE $75.20
- AVG Volume (30 Days)
- MHO 271.6K
- APGE 390.3K
- Earning Date
- MHO 10-30-2024
- APGE 11-12-2024
- Dividend Yield
- MHO N/A
- APGE N/A
- EPS Growth
- MHO 8.04
- APGE N/A
- EPS
- MHO 18.62
- APGE N/A
- Revenue
- MHO $4,271,981,000.00
- APGE N/A
- Revenue This Year
- MHO $10.87
- APGE N/A
- Revenue Next Year
- MHO $5.77
- APGE N/A
- P/E Ratio
- MHO $8.39
- APGE N/A
- Revenue Growth
- MHO N/A
- APGE N/A
- 52 Week Low
- MHO $103.62
- APGE $16.39
- 52 Week High
- MHO $176.18
- APGE $72.29
- Technical
- Relative Strength Index (RSI)
- MHO 46.13
- APGE 30.75
- Support Level
- MHO $151.54
- APGE $57.85
- Resistance Level
- MHO $157.24
- APGE $46.70
- Average True Range (ATR)
- MHO 5.39
- APGE 3.86
- MACD
- MHO -0.20
- APGE -1.57
- Stochastic Oscillator
- MHO 24.42
- APGE 0.05
About MHO M/I Homes Inc.
M/I Homes Inc is an American construction company that focuses on residential construction. It consists of two distinct operations: homebuilding and financial services. The homebuilding operations are spread into the Midwest, Mid-Atlantic, and Southern regions and the financial services operations support homebuilding operations by providing mortgage loans and title services to the customers of homebuilding operations. Homebuilding operations comprise the most significant portion of the revenue. The company builds homes and communities that target entry-level, move-up, and luxury homebuyers.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Its two programs are APG777 and APG808, which initially develop for treating AD and COPD, respectively.